Iranian Journal of Otorhinolaryngology

Iranian Journal of Otorhinolaryngology

Risk Factors for Sensorineural Hearing Loss in Children and Adolescents with Sickle Cell Disease

Document Type : Original

Authors
Solomon Amos 1
Nurudeen Adebola Shofoluwe 2
Hafsat Ahmad 1
Isa Abdulkadir 1
Shuaibu Yunusa Iliyasu 2
Manir Anka Hamza 3
1 Department of Pediatrics, Faculty of Clinical Scinces, College of Medical Sciences, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria.
2 Division of Otorhinolaryngology,Department of Surgery,Faculty of Clinical Sciences,College of Medical Sciences,Ahmadu Bello University Teaching Hospital and Ahmadu Bello University,Zaria.Kaduna State,Nigeria.
3 Department of Otorhinolaryngology, Aminu Kano Teaching Hospital, Kano, Nigeria.
10.22038/ijorl.2025.74314.3500
Abstract
Introduction: 
Sickle cell disease (SCD) is a major global health burden with significant clinical, social, and economic impacts. Sensorineural hearing loss (SNHL) is an underreported complication of SCD that is, primarily attributed to vaso-occlusive crises and ischemia. This condition adversely affects the quality of life, education, and social integration, particularly among children in resource-limited settings. Understanding the risk factors for SNHL is crucial for prevention, early detection, and timely intervention. This study evaluated the prevalence of SNHL in children with SCD and identified associated risk factors.
Materials and Methods:
This prospective comparative study was conducted at a tertiary healthcare facility in Northwest Nigeria. A total of 250 children aged 5–16 years were enrolled, comprising 125 patients with confirmed sickle cell disease (SCD) in a steady state and 125 age- and sex-matched controls with a normal haemoglobin genotype (HbAA). 
Results:
Bilateral SNHL was identified in 25.6% of SCD cases, whereas no SNHL was observed in the control group. The male-to-female ratio among the affected children was 1.2:1. Multivariate logistic regression revealed significant associations between SNHL and elevated white blood cell count (Odds Ratio {OR}  1.035; 95% Confidence Interval {CI}  1.020–1.050), elevated platelet count (OR 1.209; 95% CI 1.070–1.365), poor clinic attendance (OR 28.668; 95% CI 4.879–168.458; P= < 0.001), non-compliance  with SCD medications (OR 9.634; 95% CI 1.830–50.718; P = 0.008), and frequent severe sickle cell crises requiring hospitalization (OR 2.106,; 95% CI 0.019–0.598; P = 0.001). 
Conclusion:
This study highlights the high prevalence of SNHL in children with SCD and its association with modifiable risk factors. Routine audiological screening, consistent clinic attendance, medication adherence, and regular monitoring of haematological parameters are essential for early identification and management of SNHL. Targeted interventions can significantly improve the outcomes and reduce the burden of this debilitating complication.
Keywords
Risk factors
Sensorineural hearing loss
Sickle cell disease
Steady state
Subjects
  1. Adekile AD, Adeodu OO. Haemoglobinopathies. In : Paediatrics and Child Health in a Tropical Region. 2nd ed. Owerri - Nigeria: African Educational services 2007.
  2. Okpala IE. The concept of comprehensive care of sickle cell disease. In : Practical Management Of Haemoglobinopathies. Okpala IE, editor. Massachusettes, USA: Blackwell Publishing Ltd; 2004.
  3. Okpala IE. Epidemiology, genetics and pathophysiology of sickle cell disease. In : Practical Management of Haemoglobinopathies. IE Okpala, editor. Massachusettes, USA: Blackwell Publishing Ltd; 2004.
  4. Annie N. Farrell, April Landry, Marianne Yee, Roberta Leu, Steven Goudy. Sensorineural hearing loss in children with sickle cell disease. International Journal of Pediatric Otorhinolaryngology. 2019; 118: 110-4.
  5. Heather K, Schopper BS, Christopher F, D’Esposito BA, John S, Muus BS, et al. Childhood Hearing Loss in Patients With Sickle Cell Disease in the United States. J Pediatr Hematol Oncol. 2019; 41:124–8.
  6. Koussi A, Zafeiriou DI, Kontzoglou G, Isatra I, Noussios G, Athanassio M. Hearing loss in children with sickle cell disease. Acta Otorhinolaryngol Belg. 2001; 55(3):235-9.
  7. Alabi S, Ernest K, Eletta P, Owolabi A, Afolabi A, Suleiman O. Otological findings among Nigerian children with sickle cell anaemia. Int J Pediatr Otorhinolaryngol. 2008;72(5):659-63.
  8. Al Okbi MH, Alkindi S, Al Abri RK, Mathew J, Nagwa AA, Pathare AV. Sensorineural hearing loss in sickle cell disease--a prospective study from Oman. Laryngoscope 2011;121(2)(2):392-6.
  9. Emilie Bois, Martine Francois, Malika Benkerrou, Thierry Van Den Abbeele, Natacha Teissier. Hearing loss in children with sickle cell disease: A prospective French cohort study. Pediatr Blood Cancer. 2019;66(1):e27468.
  10. Mgbor N, Emordi F. Sensorineural hearing loss in Nigerian children with sickle cell disease. International Journal of Paediatric Otorhinolaryngology. 2004; 68(11):1413-6.
  11. Andrew Stuart, Madeline R. Smith. The emergence and prevalence of hearing loss in children with homozygous sickle cell disease. International Journal of Pediatric Otorhinolaryngology 2019;123 69–74.
  12. Alison S. Towerman, Susan S.Hayashi, Robert J. Hayashi, Monica L. Hulbert. Prevalence and nature of hearing loss in a cohort of children with sickle cell disease. Pediatric Blood & Cancer. 2018;e27457.
  13. Al-Dabbous IA, Al Jam’a AH, Obeja SK , Murugan  ANR, Hammad  Sensorineural Hearing loss in homozygous Sickle Cell Disease in Qatif, Saudi Arabia. Ann Saudi Med 1996; 16(6)(6): 64144.
  14. Ajulo SO, Osiname Al, Myatt HM. Sensorineural hearing loss in sickle cell anemia-a United Kingdom Study. J Laryngol Otol 1993;107:790-94.
  15. Friedman EM, Luban NLC, Herer GR, Williams I. Sickle cell anemia and hearing. Ann Otol Rhinol Laryngol 1980;89:342-7.
  16. Morgenstein K, Manace E. Temporal bone histopathology in sickle cell disease. Laryngoscope. 1969;79:2172-80.
  17. Ogisi FO, Okafor LA. Assessment of auditory function in sickle cell anemia patients in Nigeria. Trop Georgr Med 1986;39:28-31.
  18. Odetoyinbo O, Adekile A. Sensorineural hearing loss in children with sickle cell anemia. Ann Otol Rhinol Laryngol 1987;96:258-60.
  19. Piltcher O, Cigana L, Friedriech J, Ribeiro FA, da Costa SS. Sensorineural hearing loss among sickle cell disease patients from southern Brazil. Am J Otolaryngol. 2000;21:75-9.
  20. Taipale A, Tuula P, Luis B, Heikki P, Anne P. Hearing loss in Angolan children with sickle-cell disease. Paediatrics International. 2012;54:854-57.
  21. Todd G, Sergeant G, Larson M. Sensorineural hearing loss in Jamaicans with sickle cell disease. Acta Otolaryngol. 1973;76:268-72.
  22. United Nation General Assembly. Resolution adopted by the General Assembly on 22 December 2008. Sixty-third session Agenda item 155.
  23. World Health Organization. Sickle-Cell Anaemia, Report by the Secretariat. fifty-ninth World Health Assembly Geneva: WHO; 2006 [cited 2015 12th November]. Available from: http:// apps. who. int/gb/ ebwha/pdf_files/WHA59/A59_9-en.pdf.
  24. Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol. 2006;13(1):40-4.
  25. Araoye MO. Research Methodology with Statistics for Health and Social Sciences. Saw-Mill, Ilorin, Nigeria: Nathadex Publishers; 2004. Pg115-21 p.
  26. O'Connor AF. Examination of the ear. In: Scoff-Brown's Otolaryngology: Otology 6th ed. Kerr AG, Booth JB, Oxford: Butterworth/Heinemann 1997:pp3/1 /1-3/1/29.
  27. Campbell K. Basic Audialagic Assessment. In: Essential Audialagy far Physicians. 1st ed. DauhaeuriJ, ed. Landan: Singular Publishing Ltd. 1998:1-1 1.
  28. Childhood hearing loss: act now, here's how ! March 2016 [cited 2016 March]. Available from: http://www.who.int/iris/handle/10665/204507.
  29. Global estimates on prevalence of hearing loss - Geneva Geneva:: World Health Organization;; 2012 [cited 2013 25th November]. Available from: http:// www. who. int/pbd/ deafness/ estimates/ en/ index.html
  30. American Academy of Pediatrics. Joint Committee on Infant Hearing Position Statement. principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007; 120(4): 898-921.
  31. American Academy of Pediatrics. Committee on Practice and Ambulatory Medicine. Hearing assessment in infants and children: recommendations beyond neonatal screening. American Academy of Peiatrics. 2009;124(4):1253-63.
  32. American Speech and Hearing Association (ASHA). Guidelines for screening hearing and impairment and middle ear disorders. ASHA 1990; 32(2): 17-24.
  33. American Speech Language Hearing Association (ASHA). Definitions of Communication disorders and Variations:Hearing Disorder Section. Asha. 1993; 35(10):40-1.
  34. Awogu AU. Leucocyte counts in children with sickle cell anaemia usefulness of stable state values during infections. West Afr J Med. 2000;19(1):55-8.
  35. Ballas SK. More definitions in sickle cell disease: Steady state vs base line data. Am J Hematol 2012; 87(3): 338.
  36. Oyedeji GA. Socio-economic and Cultural Background of Hospitalized Children in Ilesa. Niger J Paed 1985;12(5):111-7.
  37. Azza A.G. Tantawya, Safaa W. Ibrahima, Togan T. Abdel-Azizb, Amr N. Rabiec, Sara M. Makkeyaha, Iman A. Ragaba. Inner Ear Complications in Children and Adolescents with Sickle Cell Disease. International journal for hemoglobin research. 2020;44:411-7.
  38. Burch-Sims GP, Matlock VR. Hearing loss and auditory function in sickle cell disease. J Commun Disord. 2005;38(4):321-9.
  39. Rissatto-Lago MR, da Cruz Fernandes L, Lyra IM T-RR, Teixeira R SC, Teixeira Ladeia AM. Hidden hearing loss in children and adolescents with sickle cell anemia. Int J Pediatr Otorhinolaryngol. 2019;116:186-91.
  40. Tantawya AAG, Ibrahima SW, Abdel-Azizb TT, Rabiec AN, Makkeyaha SM, Ragaba IA. Inner ear complications in children and adolescents with sickle cell disease. Hemoglobin 2020;44:411-7.
  41. Bois E, Francois M, Benkerrou M, Van Den Abbeele T, Teissier N. Hearing loss in children with sickle cell disease: a prospective French cohort study. Pediatr Blood Cancer. 2019;66:e27468.
  42. Bess FH, Dodd-Murphy J, Parker RA. Children with minimal sensorineural hearing loss: Prevalence, educational performance, and functional status. Ear and Hearing. 1988;19(5):339-54.
  43. Perrine RP, Pembrey ME, John P, Perrine SP, Shoup FJ. Natural history of sickle cell anemia in Saudi Arabs: a study of 270 subjects. Ann Intern Med. 2020;88(1):1-6.
  44. Crawford MR, Gould HJ, Smith WR, Beckford N, Gibson WR, Bobo L. Prevalence of hearing loss in adults with sickle cell disease. Ear and Hearing. 1991; 12(5) 349–51.
  45. Aderibigbe A, Ologe FE, Oyejola BA. Hearing thresholds in sickle cell anemia patients: emerging new trends? J Natl Med Assoc. 2005;97(8):1135-42.
  46. MacDonald CB, Bauer PW, Cox LC, McMahon L. Otologic findings in a pediatric cohort with sickle cell disease. Int J Pediatr Otorhinolaryngol 1999; 25(1): 23-8
  47. Tsibulevskaya G, Oburra H, Aluoch JR. Sensorineural hearing loss in patients with sickle cell anaemia in Kenya. East Afr Med J. 1996;73(7):471-3.
  48. Okeowo PA, Akinsete I. Sensorineural hearing loss in homozygous sickle cell patients, the Nigerian experience. Ghana Med J. 1980;4:109-13.
  49. Onakoya PAI, Nwaorgu OG , Shokunbi WA. Sensorineural hearing loss in adults with sickle cell anaemia. Afr J Med Sci. 2002;31(1): 21-4.
  50. Thalmann R, Miyoshi T, Thalmann I. The influence of ischemia upon the energy reserves of inner ear tissues. Laryngoscope. 1972;82:2249–72.
  51. Al-Saqladi AWM, Cipolotti R, Fijnvandraat K, Brabin BJ. Growth and nutritional status of children with homozygous sickle cell disease. Annals of Tropical Paediatrics. 2008;28:165-89.
  52. Lori E. Crosby, Avani C. Modi, Kathleen L. Lemanek, Shanna M. Guilfoyle, Karen A. Kalinyak, Monica J. Mitchell. Perceived Barriers to Clinic Appointments for Adolescents with Sickle Cell Disease. J Pediatr Hematol Oncol. 2009 31(8):571–6.
  53. Shannon Phillips, Yumei Chen, Rita Masese, Laurence Noisette, Kasey Jordan, Sara Jacobs, et al. Perspectives of individuals with sickle cell disease on barriers to care. PLoS ONE. 2022;17(3):e0265342.
  54. Seo YJ., Jeong JH, Choi JY, Moon IS. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: novel markers for diagnosis and prognosis in patients with idiopathic sudden sensorineural hearing loss. Dis Markers. 2014;702807.
  55. Grant D. Varieties of nerve deafness. J Laryngol Otol 1902;17:169.

 

Iranian Journal of Otorhinolaryngology
Volume 37, Issue 3
May and June 2025
Pages 123-133